Erika Zonari

2.1k total citations · 2 hit papers
14 papers, 1.5k citations indexed

About

Erika Zonari is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Erika Zonari has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Erika Zonari's work include Immune cells in cancer (4 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Erika Zonari is often cited by papers focused on Immune cells in cancer (4 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Erika Zonari collaborates with scholars based in Italy, United States and Switzerland. Erika Zonari's co-authors include Luigi Naldini, Roberta Mazzieri, Ferdinando Pucci, Michele De Palma, Bernhard Gentner, Letterio S. Politi, Davide Moi, Mary Anna Venneri, Alvise Berti and Maurilio Ponzoni and has published in prestigious journals such as Nature Communications, Blood and Nature Biotechnology.

In The Last Decade

Erika Zonari

13 papers receiving 1.5k citations

Hit Papers

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Me... 2011 2026 2016 2021 2011 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
    2011 489 citations Roberta Mazzieri, Ferdinando Pucci et al. Cancer Cell profile →
  2. Genotoxic effects of base and prime editing in human hematopoietic stem cells
    2023 93 citations Samuele Ferrari, Attya Omer et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erika Zonari Italy 9 886 700 534 344 145 14 1.5k
Katsuhiko Nakashima Japan 18 1.0k 1.2× 571 0.8× 362 0.7× 430 1.3× 111 0.8× 24 1.9k
Julie S. Nielsen Canada 20 686 0.8× 959 1.4× 927 1.7× 207 0.6× 137 0.9× 26 2.0k
Ajay K. Malik United States 10 1.1k 1.3× 437 0.6× 590 1.1× 436 1.3× 161 1.1× 16 1.8k
Theodore J. Yun United States 15 1.0k 1.1× 723 1.0× 602 1.1× 216 0.6× 67 0.5× 22 1.7k
Barbara J. Schiemann United States 15 685 0.8× 807 1.2× 484 0.9× 368 1.1× 129 0.9× 17 1.8k
Marianna B. Ruzinova United States 15 822 0.9× 225 0.3× 504 0.9× 286 0.8× 89 0.6× 36 1.4k
Ching Ching Leow United States 18 887 1.0× 501 0.7× 723 1.4× 197 0.6× 110 0.8× 33 1.7k
Kacper Jankowski United States 12 714 0.8× 346 0.5× 534 1.0× 188 0.5× 47 0.3× 15 1.4k
S. D. Gillies United States 13 980 1.1× 702 1.0× 872 1.6× 390 1.1× 242 1.7× 18 2.2k
Kalyani Penta United States 15 955 1.1× 271 0.4× 487 0.9× 120 0.3× 109 0.8× 21 1.6k

Countries citing papers authored by Erika Zonari

Since Specialization
Citations

This map shows the geographic impact of Erika Zonari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Zonari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Zonari more than expected).

Fields of papers citing papers by Erika Zonari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Zonari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Zonari. The network helps show where Erika Zonari may publish in the future.

Co-authorship network of co-authors of Erika Zonari

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Zonari. A scholar is included among the top collaborators of Erika Zonari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Zonari. Erika Zonari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ferrari, Samuele, Attya Omer, Stefano Beretta, et al.. (2023). Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nature Biotechnology. 42(6). 877–891. 93 indexed citations breakdown →
2.
Ferrari, Samuele, Attya Omer, Stefano Beretta, et al.. (2023). P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS. HemaSphere. 7(S3). e6237653–e6237653. 1 indexed citations
3.
Naldini, Matteo Maria, Matteo Barcella, Paola M. V. Rancoita, et al.. (2023). Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia. Nature Communications. 14(1). 1285–1285. 41 indexed citations
4.
Gentner, Bernhard, Maria Ester Bernardo, Francesca Tucci, et al.. (2021). Ex vivo hematopoietic stem cell gene therapy for mucopolysaccharidosis type I (Hurler syndrome). Molecular Genetics and Metabolism. 132(2). S42–S43.
5.
Bernardo, Maria Ester, Bernhard Gentner, Francesca Tucci, et al.. (2019). PS1220 EX‐VIVO HEMATOPOIETIC STEM CELL GENE THERAPY (GT) FOR MUCOPOLYSACCHARIDOSIS TYPE I HURLER (MPSIH): PRELIMINARY RESULTS FROM A PHASE I/II CLINICAL STUDY. HemaSphere. 3(S1). 556–557. 1 indexed citations
6.
Gentner, Bernhard, Maria Ester Bernardo, Francesca Tucci, et al.. (2019). Extensive Metabolic Correction of Hurler Disease By Hematopoietic Stem Cell-Based Gene Therapy: Preliminary Results from a Phase I/II Trial. Blood. 134(Supplement_1). 607–607. 3 indexed citations
7.
Naldini, Matteo Maria, Erika Zonari, Giacomo Desantis, et al.. (2018). Dissecting Ex Vivo Expansion of Mobilized Peripheral Blood Hematopoietic Stem and Progenitor Cells By Single Cell RNA Sequencing. Blood. 132(Supplement 1). 3343–3343. 1 indexed citations
8.
Zonari, Erika, Giacomo Desantis, Carolina Petrillo, et al.. (2017). Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy. Stem Cell Reports. 8(4). 977–990. 117 indexed citations
9.
Chiriacò, Maria Serena, Giada Farinelli, Valentina Capo, et al.. (2014). Dual-regulated Lentiviral Vector for Gene Therapy of X-linked Chronic Granulomatosis. Molecular Therapy. 22(8). 1472–1483. 49 indexed citations
10.
Zonari, Erika, Ferdinando Pucci, Massimo Saini, et al.. (2013). A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. Blood. 122(2). 243–252. 102 indexed citations
11.
Mazzieri, Roberta, Ferdinando Pucci, Davide Moi, et al.. (2011). Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells. Cancer Cell. 19(4). 512–526. 489 indexed citations breakdown →
12.
Palma, Michele De, Roberta Mazzieri, Letterio S. Politi, et al.. (2008). Tumor-Targeted Interferon-α Delivery by Tie2-Expressing Monocytes Inhibits Tumor Growth and Metastasis. Cancer Cell. 14(4). 299–311. 235 indexed citations
13.
Venneri, Mary Anna, Michele De Palma, Maurilio Ponzoni, et al.. (2007). Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood. 109(12). 5276–5285. 393 indexed citations
14.
Mazzieri, Roberta, Federico Furlan, Silvia D’Alessio, et al.. (2006). A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts. Oncogene. 26(5). 725–732. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuhiko Nakashima Breakdown of academic impact, for papers by Julie S. Nielsen Breakdown of academic impact, for papers by Ajay K. Malik Breakdown of academic impact, for papers by Theodore J. Yun Breakdown of academic impact, for papers by Barbara J. Schiemann Breakdown of academic impact, for papers by Marianna B. Ruzinova Breakdown of academic impact, for papers by Ching Ching Leow Breakdown of academic impact, for papers by Kacper Jankowski Breakdown of academic impact, for papers by S. D. Gillies Breakdown of academic impact, for papers by Kalyani Penta
Rankless by CCL
2026